Incorporated in 1911, International Business Machines, or IBM, is one of the oldest technology companies in the world... Show more
IBM maintains a differentiated position in the enterprise technology landscape through its focus on hybrid cloud and AI platforms. Unlike pure-play public cloud providers, IBM emphasizes hybrid and multicloud environments, enabling clients to integrate on-premises systems with cloud services via Red Hat OpenShift and watsonx AI suite. This approach resonates with regulated industries like finance and healthcare, where data sovereignty and security are paramount.
The company's software segment, which grew 11% year-over-year in Q1 2026, underscores its competitive edge in automation, data management, and transaction processing. Red Hat's hybrid cloud platform continues to gain traction, with double-digit growth anticipated. IBM's consulting services further strengthen its ecosystem, helping enterprises deploy AI responsibly. Medium-term, IBM's innovation in generative AI and quantum computing positions it for market share gains, though it trails hyperscalers in public cloud scale.
The Q2 2026 earnings release on July 22 will be pivotal, with analysts forecasting revenue of $17.83 billion and EPS of $2.98. Investors will scrutinize updates on AI bookings, which have shown robust momentum, and software growth trends. IBM's reaffirmation or raise of full-year guidance—targeting over 5% constant currency revenue growth—could boost sentiment.
Recent analyst actions reflect cautious optimism: firms like Stifel and Citi maintain Buy ratings with targets around $285-$290, while some trimmed targets pre-Q1 amid valuation concerns. Consensus remains overweight, with price targets implying 20-25% upside. Strategic deals, such as expansions in AI governance or partnerships, could also drive positive revisions.
Regulatory developments in AI ethics and data privacy may favor IBM's compliant, enterprise-focused offerings, enhancing investor confidence.
IBM's trajectory is closely tied to enterprise AI adoption, projected to surge 150% in investments through 2030, and hybrid cloud demand as firms avoid vendor lock-in. Technology transitions toward agentic AI and sovereign data models align with IBM's strengths.
Macro factors include moderating interest rates, which could spur IT capital expenditures, and persistent inflation pressuring margins. Geopolitical tensions may accelerate onshoring and hybrid strategies, benefiting IBM. Conversely, economic slowdowns could delay AI projects, heightening sensitivity to consumer and enterprise demand cycles.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that assists traders in identifying potential bullish, bearish, or sideways movements for stocks, ETFs, and other assets over the next week or month. By analyzing vast datasets, it spots emerging trends, evaluates breakout or reversal opportunities, and provides predictions across thousands of tradable instruments. Features include searchable prediction categories, historical performance context, and customizable alerts to keep users ahead of market shifts. Explore the Trend Prediction Engine to enhance your trading decisions with data-driven insights.
For 2026, IBM guides to over 5% constant currency revenue growth and $1 billion FCF increase, with consensus estimates at $71.43 billion in revenue (5.77% growth) and $12.42 EPS. Software acceleration, driven by hybrid cloud and AI, remains central, alongside infrastructure demand from mainframes like IBM Z.
Long-term themes include margin expansion through high-value AI services, cost efficiencies from automation, and market expansion in emerging AI applications. Competitive threats from Microsoft and AWS persist, but IBM's focus on regulated sectors and open hybrid ecosystems offers resilience. Watch capital allocation—dividend hikes to $1.69 quarterly signal commitment to shareholders—and regulatory evolution in AI governance. Analyst consensus anticipates 7-8% EPS growth into 2027, reflecting optimism in structural shifts.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a manufacturer of various computer products through the use of advanced information technology
Industry InformationTechnologyServices
A.I.dvisor indicates that over the last year, IBM has been loosely correlated with CTSH. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IBM jumps, then CTSH could also see price increases.
| Ticker / NAME | Correlation To IBM | 1D Price Change % | ||
|---|---|---|---|---|
| IBM | 100% | +0.91% | ||
| CTSH - IBM | 53% Loosely correlated | -1.24% | ||
| DXC - IBM | 49% Loosely correlated | N/A | ||
| ACN - IBM | 48% Loosely correlated | -1.75% | ||
| CNXC - IBM | 46% Loosely correlated | +2.00% | ||
| GIB - IBM | 45% Loosely correlated | +0.10% | ||
More | ||||
| Ticker / NAME | Correlation To IBM | 1D Price Change % |
|---|---|---|
| IBM | 100% | +0.91% |
| Technology Services category (400 stocks) | 41% Loosely correlated | +1.22% |
The 10-day moving average for IBM crossed bullishly above the 50-day moving average on May 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Momentum Indicator moved above the 0 level on May 20, 2026. You may want to consider a long position or call options on IBM as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
IBM moved above its 50-day moving average on May 21, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where IBM advanced for three days, in of 371 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 268 cases where IBM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for IBM moved out of overbought territory on June 04, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 46 similar instances where the indicator moved out of overbought territory. In of the 46 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Moving Average Convergence Divergence Histogram (MACD) for IBM turned negative on June 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
IBM broke above its upper Bollinger Band on May 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.837) is normal, around the industry mean (7.314). P/E Ratio (24.323) is within average values for comparable stocks, (68.402). IBM's Projected Growth (PEG Ratio) (2.567) is slightly higher than the industry average of (1.063). Dividend Yield (0.024) settles around the average of (0.027) among similar stocks. P/S Ratio (3.791) is also within normal values, averaging (17.144).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IBM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.